The next giant step for microbes – Nature Biotechnology
A microbiome therapy is approved by the FDA for treatment of Clostridioides difficile. What’s next?
A microbiome therapy is approved by the FDA for treatment of Clostridioides difficile. What’s next?
The deep learning-based Lifelong Neural Network for Gene Regulation tool may shed light on how genetic variations influence a patient’s drug response.
Exploiting the efforts of millions of gamers has helped advance our knowledge of the human microbiome
Nature Awards Microbiome Accelerator – Translating science from lab to impact.
Two people are prescribed the same drug to treat the same ailment. It works for one but not the other. Researchers are studying the genetic…
Nature Cell Biology – Reicher, Reiniš et al. report a method for multicolour tagging using genome-scale intron-targeting sgRNA libraries that, in combination with computer vision,…
Millions of Borderlands 3 players are now collectively listed as contributors to a peer reviewed scientific paper, after participating in a minigame that helped provide…
Nature Biotechnology – Metrics that predict the success of folding and the activity of designed protein sequences are developed and experimentally validated.
A new initiative backed by Takeda, Astellas and Sumitomo Mitsui Banking aims to combat a decade-long decline in drug R&D productivity in Japan.
Nature Methods – Generating training data for training deep-learning-based tools is time consuming. The DELiVR pipeline facilitates this process as demonstrated in this study on…
Nature Biotechnology – RoseTTAFold expands to all-atom for biomolecular prediction and design